After CIITA-expressing ovarian cancer cell lines were pulsed with NY-ESO-1157–170 peptide, they were efficiently recognized by both NTR-CD4 as well as TR-CD4 (Supplementary Fig. S1B). This evidence concerns the gene CD4 and ovarian carcinoma.